Dr Ashley M Whittington : Infectious diseases

Home
Dr Ashley M Whittington

Bupa Platinum consultant
Fee assured
Verified account
Open Referral network

Overview

Offers

Face-to-face consultations
Video and telephone consultations

About me

I am a Consultant Physician in Infectious Diseases and General Medicine and have a busy NHS practice at London North West NHS Trust. I have wide experience diagnosing and treating both acute and chronic infections. This includes fever in returning travellers and fever of unknown cause, Tuberculosis, HIV and complex urinary and skin infections. Diagnosing and excluding infectious diseases as a cause of unknown illness is a key part of my practice. I also specialise in ambulatory infection services to provide rapid diagnosis and treatment of patients to minimise hospital stay. My academic interests focus on TB and delivering clinical research to give my patients access to the latest treatments. I have a PhD from Imperial College in TB Immunology and supervise research investigating links between Tuberculosis and diabetes. I have authored several scientific papers on TB. I am currently Principal Investigator for several clinical trials studying treatment of viral respiratory infections, pneumonia and TB and several vaccine studies.

Empowering patients to understand their health needs and allowing them to be central to decision making is key to my practice.

Medical secretaries

Sharon Huntley
Department of infectious Diseases Private Patients Clinic Northwick Park Hospital Watford Road Harrow HA1 3UJ
020 8869 5329
07816 60349
sharon.huntley@nhs.net

About me

Current NHS consultant posts held

Consultant in Infectious Diseases and Acute Medicine, Northwick Park Hospital, London North West University NHS Trust

Clinical Lead for the North West London Clinical Research Facility

Research interests

Tuberculosis
Vaccines

Personal interests

Scuba Diving

Publications

� Drug management of TB in the intensive care setting: an international multicentre study.
Tiberi S, Akkerman O, Sotgiu G, Saderi L��.. Whittington A, Martin-Lazaro JF, White V, Chen C, Gray A, Brown M, Alffenaar JC, Bruchfeld J, Centis R, D'Ambrosio L, Ruslami R, Kerstjens HAM, Zumla A, Ambrosino N, Migliori GB.Int J Tuberc Lung Dis. 2025 Aug 1;29(8):340-348. doi: 10.5588/ijtld.24.0597.PMID: 40751207
� An acidic microenvironment in Tuberculosis increases extracellular matrix degradation by regulating macrophage inflammatory responses
Whittington AM, Turner FS, BaarK F, Templeman S, Kirwan DE�..Friedland JS Plos Pathog 2023 Jul 7;19(7)
� Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study.
Bruyn de G, Wang J, Purvis A, Ruiz MS, Adhikarla H, Alvi S, Bonaparte M �Whittington A, Chicz R, Gurunathan S, Savarino S, Srindhar S EClinical Medicine 2023 Jul 22:62:102109
� Diabetes mellitus in not a predictor of poor TB Treatment outcomes
Baltas I, Sturdy A, Kavallieros K, McGregor A, Corrah T, John L, Cooke G, Whittington AM Int J Tuberc Lung Dis. 2023 Feb 1;27(2):140-145
� The first three reported cases of Sporothrix brasiliensis cat-transmitted sporotrichosis outside South America
Barnacle JR, Chow YJ, Borman AM, Wyllie S, Dominguez V, Russell K, Roberts H, Armstrong-James D, Whittington AM Med Mycol Case Reports 2022 Dec 20;39:14-17
� Increase in disseminated tuberculosis during the COVID-19 pandemic
Barrett J, Painter H, Rajgopal A, Keane D, John L, Papineni P, Whittington AM Int J Tuberc Lung Di 2021 Feb 1;25(2):160-166.
� Risk factors for severe disease in patients admitted with COVID-19 to a hospital in London, England: a retrospective review Goodall JW, Reed TAN, Ardissino M, Bassett P, Whittington AM, Cohen D, Vaid N Epidemiology and Infection 2020 Oct 13

My qualifications & training

Report this page

Finder

Note: